A phage protein-derived antipathogenic peptide that targets type IV pilus assembly

References

• Mullard A. Tackling antimicrobial drug resistance. Nat Rev Drug Discov. 2016;15:375.
   Web of Science ®Google Scholar
• Dadgostar P. Antimicrobial resistance: implications and costs. Infect Drug Resist. 2019;12:3903–3910.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2019 antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline. Geneva, Switzerland: WHO; 2019.
   Google Scholar
• Kortright KE, Chan BK, Koff JL, et al. Phage therapy: a renewed approach to combat antibiotic-resistant bacteria. Cell Host Microbe. 2019;25:219–232.
   PubMed Web of Science ®Google Scholar
• Theuretzbacher U, Piddock LJV. Non-traditional antibacterial therapeutic options and challenges. Cell Host Microbe. 2019;26:61–72.
   PubMed Web of Science ®Google Scholar
• Kim B-O, Kim ES, Yoo Y-J, et al. Phage-derived antibacterials: harnessing the simplicity, plasticity, and diversity of phages. Viruses. 2019;11:268.
   PubMed Web of Science ®Google Scholar
• Lu TK, Koeris MS. The next generation of bacteriophage therapy. Curr Opin Microbiol. 2011;14:524–531.
   PubMed Web of Science ®Google Scholar
• De Smet J, Hendrix H, Blasdel BG, et al. Pseudomonas predators: understanding and exploiting phage-host interactions. Nat Rev Microbiol. 2017;15:517–530.
   PubMed Web of Science ®Google Scholar
• Howard-Varona C, Lindback MM, Bastien GE, et al. Phage-specific metabolic reprogramming of virocells. ISME J. 2020;14:881–895.
   PubMed Web of Science ®Google Scholar
• Bondy-Denomy J, Pawluk A, Maxwell KL, et al. Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature. 2013;493:429–432.
   PubMed Web of Science ®Google Scholar
• Chevallereau A, Blasdel BG, De Smet J, et al. Next-generation “-omics” approaches reveal a massive alteration of host RNA metabolism during bacteriophage infection of Pseudomonas aeruginosa. PLoS Genet. 2016;12:e1006134.
   PubMed Web of Science ®Google Scholar
• Conter A, Bouche JP, Dassain M. Identification of a new inhibitor of essential division gene ftsZ as the kil gene of defective prophage Rac. J Bacteriol. 1996;178:5100–5104.
   PubMed Web of Science ®Google Scholar
• Lavigne R, Lecoutere E, Wagemans J, et al. A multifaceted study of Pseudomonas aeruginosa shutdown by virulent podovirus LUZ19. mBio. 2013;4:e00061–13.
   PubMed Web of Science ®Google Scholar
• Chung I-Y, Sim N, Cho Y-H. Antibacterial efficacy of temperate phage-mediated inhibition of bacterial group motilities. Antimicrob Agents Chemother. 2012;56:5612–5617.
   PubMed Web of Science ®Google Scholar
• Burrows LL. Pseudomonas aeruginosa twitching motility: type IV pili in action. Annu Rev Microbiol. 2012;66:493–520.
   PubMed Web of Science ®Google Scholar
• Skerker JM, Berg HC. Direct observation of extension and retraction of type IV pili. Proc Natl Acad Sci U S A. 2001;98:6901–6904.
   PubMed Web of Science ®Google Scholar
• Craig L, Pique ME, Tainer JA. Type IV pilus structure and bacterial pathogenicity. Nat Rev Microbiol. 2004;2:363–378.
   PubMed Web of Science ®Google Scholar
• Hahn HP. The type-4 pilus is the major virulence-associated adhesin of Pseudomonas aeruginosa. Gene. 1997;192:99–108.
   PubMed Web of Science ®Google Scholar
• Ogawara H. Possible drugs for the treatment of bacterial infections in the future: anti-virulence drugs. J Antibiot. 2020. DOI:10.1038/s41429-020-0344-z
   PubMed Web of Science ®Google Scholar
• Pinkner JS, Remaut H, Buelens F, et al. Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria. Proc Natl Acad Sci U S A. 2006;103:17897–17902.
   PubMed Web of Science ®Google Scholar
• Chung I-Y, Jang H-J, Bae H-W, et al. A phage protein that inhibits the bacterial ATPase required for type IV pilus assembly. Proc Natl Acad Sci U S A. 2014;111:11503–11508.
   PubMed Web of Science ®Google Scholar
• Sato AK, Viswanathan M, Kent RB, et al. Therapeutic peptides: technological advances driving peptides into development. Curr Opin Biotechnol. 2006;17:638–642.
   PubMed Web of Science ®Google Scholar
• Kim ES, Bae H-W, Cho Y-H. A pilin region affecting host range of the pseudomonas aeruginosa RNA phage, PP7. Front Microbiol. 2018;9:247.
   PubMedGoogle Scholar
• Bechara C, Sagan S. Cell-penetrating peptides: 20 years later, where do we stand? FEBS Lett. 2013;587:1693–1702.
   PubMed Web of Science ®Google Scholar
• Conrad RS, Gilleland HE. Lipid alterations in cell envelopes of polymyxin-resistant Pseudomonas aeruginosa isolates. J Bacteriol. 1981;148:487–497.
   PubMed Web of Science ®Google Scholar
• Kim B-O, Jang H-J, Chung I-Y, et al. Nitrate respiration promotes polymyxin B resistance in Pseudomonas aeruginosa. Antioxid Redox Signal. 2021;34:442–451.
   PubMed Web of Science ®Google Scholar
• Pollitt EJ, Crusz SA, Diggle SP. Staphylococcus aureus forms spreading dendrites that have characteristics of active motility. Sci Rep. 2015;5:1–12.
   Web of Science ®Google Scholar
• Park S-Y, Heo Y-J, Choi Y-S, et al. Conserved virulence factors of Pseudomonas aeruginosa are required for killing Bacillus subtilis. J Microbiol. 2005;43:443–450.
   PubMed Web of Science ®Google Scholar
• Drulis-Kawa Z, Majkowska-Skrobek G, Maciejewska B, et al. Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications. Curr Protein Pept Sci. 2012;13:699–722.
   PubMed Web of Science ®Google Scholar
• Van Den Bossche A, Ceyssens P-J, De Smet J, et al. Systematic identification of hypothetical bacteriophage proteins targeting key protein complexes of Pseudomonas aeruginosa. J Proteome Res. 2014;13:4446–4456.
   PubMed Web of Science ®Google Scholar
• Liu J, Dehbi M, Moeck G, et al. Antimicrobial drug discovery through bacteriophage genomics. Nat Biotechnol. 2004;22:185–191.
   PubMed Web of Science ®Google Scholar
• Bae H-W, Cho Y-H. Complete genome sequence of Pseudomonas aeruginosa podophage MPK7, which requires Type IV pili for infection. Genome Announc. 2013;1:e00744–13.
   PubMedGoogle Scholar
• Kiro R, Molshanski-Mor S, Yosef I, et al. Gene product 0.4 increases bacteriophage T7 competitiveness by inhibiting host cell division. Proc Natl Acad Sci U S A. 2013;110:19549–19554.
   PubMed Web of Science ®Google Scholar
• Yano ST, Rothman-Denes LB. A phage-encoded inhibitor of Escherichia coli DNA replication targets the DNA polymerase clamp loader. Mol Microbiol. 2011;79:1325–1338.
   PubMed Web of Science ®Google Scholar
• Bradley DE. A function of Pseudomonas aeruginosa PAO polar pili: twitching motility. Can J Microbiol. 1980;26:146–154.
   PubMed Web of Science ®Google Scholar
• Mattick JS. Type IV pili and twitching motility. Annu Rev Microbiol. 2002;56:289–314.
   PubMed Web of Science ®Google Scholar
• O’Toole GA, Kolter R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol. 1998;30:295–304.
   PubMed Web of Science ®Google Scholar
• Tala L, Fineberg A, Kukura P, et al. Pseudomonas aeruginosa orchestrates twitching motility by sequential control of type IV pili movements. Nat Microbiol. 2019;4:774–780.
   PubMed Web of Science ®Google Scholar
• Howie HL, Glogauer M, So M. The N. gonorrhoeae type IV pilus stimulates mechanosensitive pathways and cytoprotection through a pilT-dependent mechanism. PLoS Biol. 2005;3:e100.
   PubMed Web of Science ®Google Scholar
• Persat A, Inclan YF, Engel JN, et al. Type IV pili mechanochemically regulate virulence factors in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A. 2015;112:7563–7568.
   PubMed Web of Science ®Google Scholar
• Bertozzi Silva J, Storms Z, Sauvageau D. Host receptors for bacteriophage adsorption. FEMS Microbiol Lett. 2016;363:fnw002.
   PubMed Web of Science ®Google Scholar
• Heo Y-J, Chung I-Y, Choi KB, et al. Genome sequence comparison and superinfection between two related Pseudomonas aeruginosa phages, D3112 and MP22. Microbiology. 2007;153:2885–2895.
   PubMed Web of Science ®Google Scholar
• Wolfgang M, Van Putten JP, Hayes SF, et al. Components and dynamics of fiber formation define a ubiquitous biogenesis pathway for bacterial pili. EMBO J. 2000;19:6408–6418.
   PubMed Web of Science ®Google Scholar
• Karimova G, Pidoux J, Ullmann A, et al. A bacterial two-hybrid system based on a reconstituted signal transduction pathway. Proc Natl Acad Sci U S A. 1998;95:5752–5756.
   PubMed Web of Science ®Google Scholar
• Brand AH, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development. 1993;118:401–415.
   PubMed Web of Science ®Google Scholar
• Lee J-Y, Ahn S-J, Park C, et al. Reverse genetic systems for Pseudomonas aeruginosa leviphages. Methods Protoc. 2019;2:21.
   PubMedGoogle Scholar
• Kim S-H, Park S-Y, Heo Y-J, et al. Drosophila melanogaster-based screening for multihost virulence factors of Pseudomonas aeruginosa PA14 and identification of a virulence-attenuating factor, HudA. Infect Immun. 2008;76:4152–4162.
   PubMed Web of Science ®Google Scholar
• Jang H-J, Chung I-Y, Lim C, et al. Redirecting an anticancer to an antibacterial hit against methicillin-resistant Staphylococcus aureus. Front Microbiol. 2019;10:350.
   PubMed Web of Science ®Google Scholar